Mary-Beth Moore Joshi

机构：Duke University

发表论文 24 篇 · 总被引 303 次 · h-index 5

代表论文

• High Gene Expression of TS1, GSTP1, and ERCC1 Are Risk Factors for Survival in Patients Treated with Trimodality Therapy for Esophageal Cancer (2005 · Clinical Cancer Research · 被引 139)
• Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma (2018 · Journal of Thoracic Oncology · 被引 85)
• Neighborhood‐level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States (2012 · Cancer · 被引 74)
• Measurement of chemoresistance markers in patients with stage iii non–small cell lung cancer: a novel approach for patient selection (2003 · The Annals of Thoracic Surgery · 被引 51)
• Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023 · The Lancet Respiratory Medicine · 被引 19)
• Serum Protein Expression Predicts Recurrence in Patients With Early-Stage Lung Cancer After Resection (2006 · The Annals of Thoracic Surgery · 被引 19)